Scientific Programme - Satellite Symposia


Merritt Putnam Symposium - The Role of Inflammation in the Development of Epilepsy
Session Chair - Wolfgang Loescher, Germany,   Annamaria Vezzani, Italy
21/09/2008, 1630 - 1800

Is inflammation a common factor in various forms of epilepsy? Experimental observations
Annamaria Vezzani, Italy

Febrile seizures, brain inflammation and epilepsy
Tallie Z  Baram, USA

Seizures, epilepsy and inflammatory diseases of the CNS: A clinical perspective
Tapani  Keränen, Finland

Valeant Satellite Symposium - Neuron-Specific M-Current K+ Channels: A New Target in Managing Epilepsy
Session Chair - Emilio Perucca, Italy
21/09/2008, 1430 - 1600

The need for novel antiepileptic drugs
Jacqueline A. French, USA

Anatomy and physiology of M-current K+ channels
Holger Lerche, Germany

Pharmacology of M-current K+ channel activation
H. Steve White USA

Clinical evidence of K+ channels as a therapeutic target
Jacqueline A. French, USA

EISAI Satellite Symposium - What type of data makes you pick your drug?  An expert panel discussion
 Session Chair -  Josemir W Sander, UK
22/09/2008, 1830 - 2000

Randomised controlled trials: understanding their true value
Michel Baulac, France 

Beyond placebo: the role of open-label extensions
Stephen Wroe, UK

Bridging the gap: what can we learn from naturalistic studies
Eugen Trinka, Austria 

Focus on the patient: quality of life
Joyce Kramer, USA

UCB Satellite Symposium - Raising expectations in the management of Partial Onset Seizures
 Session Chair -  Gunter Kramer, Switzerland
22/09/2008, 1630 - 1800

Does Mode of Action generate synergistic effects?
Philippe Ryvlin, France

Ideal PK characteristics for AEDs for use as first add-on in partial onset seizures
Philip N. Patsalos, UK

Clinical considerations when adding a second AED
Gregory Krauss, USA

Janssen Cilag Satellite Symposium - Practical Issues of Drug Therapy - How to Avoid Pitfalls
 Session Chair -  Hermann Stefan, Germany
23/09/2008, 1830 - 2000

First Monotherapy - Evidence and Experience
Elinor Ben Menachem, Sweden

Drug Therapy in the Elderly - Some Evidence, but more Experience
Hermann Stefan, Germany

Failure of First Monotherapy - Little Evidence, but a lot of Experience
Kork  Steinhoff, Germany

The New Drugs Symposium
Session Chair -  H. Steve White, USA
Michel  Baulac, France
24/09/2008, 1630 - 1800

Progress Report on New Antiepileptic Drugs in Development - An Update of the Ninth Eilat Conference (Eilat ІХ)
H. Steve White, USA

An Update on Brivaracetam Development – Supported by UCB SA
Philipp Von Rosenstiel, Belgium

Efficacy and Safety of Eslicarbazepine Acetate (ESL) as adjunctive therapy for partial seizures – Supported by BIAL
Elinor Ben Menachem, Sweden